- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Success of Telemonitoring Systems Hinges on Features, Design
The success of mobile phone telemonitoring systems hinges both on their features and design, a study focusing on heart failure patients published late last week in theJournal of Medical Internet Research concluded. In particular, characteristics that led to improved care for such patients included ease of use, as well as immediate clinical
feedback with self-care instructions, according to researchers.
While the study was small--it used data from 22 patients attending the University Health Network Heart Function Clinic in Toronto over a 6-month period--the study's authors said that patients became more self-aware of their own behaviors, which improved their care-related actions.
No issues with regard to usage were found, and even those patients with little or no experience with mobile phones were successful in using the system.
Read more at: http://tinyurl.com/7vcf7g4
Source: FierceHealthIT
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Intermountain Healthcare and Story Health Partner to Optimize Rural Heart Failure Care
February 7th 2023On this episode of Managed Care Cast, we speak with Tom Stanis, CEO and cofounder of Story Health, and Phillip Wood, Intermountain Ventures program director, on how their partnership came about, how it is going so far, and the future of their collaboration.
Listen
Midodrine Use Linked to Decrease in HFrEF-Related ED Visits
March 23rd 2024However, researchers saw higher risks of respiratory failure, longer stays in the intensive care unit, increased hospitalizations, and elevated mortality rates in patients with heart failure with reduced ejection fraction (HFrEF) taking the antihypotensive medication.
Read More
